It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Apicomplexan parasites have immense impacts on humanity, but their basic cellular processes are often poorly understood. Where endocytosis occurs in these cells, how conserved this process is with other eukaryotes, and what the functions of endocytosis are across this phylum are major unanswered questions. Using the apicomplexan model Toxoplasma, we identified the molecular composition and behavior of unusual, fixed endocytic structures. Here, stable complexes of endocytic proteins differ markedly from the dynamic assembly/disassembly of these machineries in other eukaryotes. We identify that these endocytic structures correspond to the ‘micropore’ that has been observed throughout the Apicomplexa. Moreover, conserved molecular adaptation of this structure is seen in apicomplexans including the kelch-domain protein K13 that is central to malarial drug-resistance. We determine that a dominant function of endocytosis in Toxoplasma is plasma membrane homeostasis, rather than parasite nutrition, and that these specialized endocytic structures originated early in infrakingdom Alveolata likely in response to the complex cell pellicle that defines this medically and ecologically important ancient eukaryotic lineage.
Apicomplexan parasites share complex cell pellicular structures that isolates the cytosol from most of the plasma membrane. Koreny et al show that, as an early adaptation to this barrier, dedicated stable endocytic structures occur at select sites in these cells. In Toxoplasma, plasma membrane homeostasis is particularly dependent on endocytosis.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details







1 University of Cambridge, Department of Biochemistry, Cambridge, UK (GRID:grid.5335.0) (ISNI:0000000121885934)
2 University of Alberta, Division of Infectious Diseases, Department of Medicine, Edmonton, Canada (GRID:grid.17089.37) (ISNI:0000 0001 2190 316X)
3 University of Cambridge, Cambridge Institute for Medical Research, Cambridge, UK (GRID:grid.5335.0) (ISNI:0000000121885934)
4 University of Michigan Medical School, Department of Microbiology and Immunology, Ann Arbor, USA (GRID:grid.214458.e) (ISNI:0000000086837370)
5 Plant Development, Ludwig-Maximilians-University Munich, Planegg-Martinsried, Germany (GRID:grid.5252.0) (ISNI:0000 0004 1936 973X)
6 University of Alberta, Division of Infectious Diseases, Department of Medicine, Edmonton, Canada (GRID:grid.17089.37) (ISNI:0000 0001 2190 316X); Institute of Parasitology, Biology Centre, Czech Academy of Sciences, České Budějovice, Czech Republic (GRID:grid.418095.1) (ISNI:0000 0001 1015 3316)
7 Ludwig-Maximilians-University Munich, Experimental Parasitology, Department for Veterinary Sciences, Planegg-Martinsried, Germany (GRID:grid.5252.0) (ISNI:0000 0004 1936 973X)